SPEAKERS INCLUDE:

 

REGISTER NOW

tal zaks disease prevention and control

 

Tal Zaks, Chief Medical Officer, Moderna

Tal oversees preclinical development, clinical development and regulatory affairs across Moderna, a vaccine biotech showing some of the most promising results for a COVID-19 vaccination in development.

Phase III trials for the Moderna COVID-19 vaccine are set to begin at the end of July 2020.

jacob glanville disease prevention and control

 

Jacob Glanville PHD , Founding Partner, CEO and President, Distributed Bio

Jacob and his teams apply computationally-guided immunoengineering methods to enable a new generation of monoclonal antibody discovery and universal vaccine design. Jacob is also the inventor of the Centivax universal vaccine technology for influenza, HIV, and other rapidly mutating pathogens

Fun fact: Netflix covered Jacob and his team in their hit documentary ‘Pandemic’

Rino Rappouli Disease Prevention and Control

 

Rino Rappuoli , Chief Scientist & Head of External Research and Development (R&D), GlaxoSmithKline Vaccines

Rino is globally known for his extensive work in vaccines and immunology, and is actively involved in the research and development of vaccines against meningococcal disease, and avian and pandemic influenza. 

Rino led the development of the first recombinant bacterial vaccine against pertussis, the adjuvanted influenza vaccines, and the conjugate vaccine against meningococcal-C disease.

henry ji disease prevention and control

 

Henry Ji , Chairman, President and CEO, Sorrento Therapeutics

Henry co-founded Sorrento Therapeutics in 2006, with an aim to develop therapeutic approaches for cancer. More recently, Sorrento Therapeutics have been active in the COVID-19 space with an antibody cocktail called COVI-SHIELD, and the newly launched I-Cell COVID-19 Cellular Vaccine Program, which is expected to elicit both T cell and B cell immunities against SARS-CoV-2. 

neeta verma Disease Prevention and Control

 

Neeta Verma , Director General, National Informatics Center, Government of India

Neeeta has been instrumental in implementing high impact digital initiatives across India, and is involved in the launch and development of the breakthrough contact-tracing app Aarogya Setu, to track COVID-19 movements in India.

The app currently sits at over 100 million downloads, and is one of the most advanced and widely used contact tracing apps to date. 

kate broderick disease prevention and control

 

Kate Broderick , Vice President, Research and Development, Inovio Pharmaceuticals

Kate has a broad background in the product development and device development DNA therapeutic and drug delivery field, with specific expertise in in vivo DNA vaccine animal studies and product development in relation to electroporation.

She is also a co-inventor on multiple patents related to DNA vaccine delivery and is principal investigator on grants, awards and contracts from funding bodies such as NIH, Department of Defence and SBIR.

Laura Kahn Disease Prevention and Control

 

Laura Kahn , Research Scholar, Princeton University , Co-Founder, One Health Initiative

Laura co-founded the One Health Initiative, which seeks to improve the health of all species by increasing communication and collaboration between human, animal and environmental health specialists. She is an expert advisor in the field of zoonosis and has published a number of books on topics surrounding the politics of antimicrobial resistance, one health, and trust in leadership during epidemics. 

Fun fact: The 2nd Edition of Laura’s book “Who’s in Charge?: Leadership during Epidemics, Bioterror Attacks, and Other Public Health Crises” was published earlier this year.

peter marks disease prevention and control

 

Peter Marks , Director, Center for Biologics Evaluation and Research (CBER), FDA

Peter has been with CBER since 2012, becoming Board Director in 2016, is board certified in internal medicine, hematology, medical oncology, and is a Fellow of the American College of Physicians. CBER is responsible for assuring the safety, purity, potency and effectiveness of biologics and related products, such as vaccines and cell therapies. 

lisa jarvis Disease Prevention and Control

 

Lisa Jarvis , Senior Correspondent, C&EN

Lisa tracks big pharma and biotech companies, and specialises in weaving together the business and science between developing drugs, and has reported on important issues such as Ebola, orphan drugs, gender diversity in the drug industry and more recently, COVID-19. Articles to note include “How big pharma firms are quietly collaborating on new coronavirus antivirals” and “The race to pick the best medicines to try against coronavirus”.

Get Your Free Pass

 

All Speakers:

Philip Alberti, Senior Director, Health Equity Research and Policy, Association Of American Medical Colleges Aamc

Jennifer Avegno, Director, New Orleans Health Department

Andrew Baguma, Laboratory Consultant, COVID-19 Response, World Health Organisation

Nir Barzilai, Director of the Institute For Aging Research, Albert Einstein College of Medicine

Kirsten Bibbins-Domingo, Chairman, Department Of Epidemiology And Biostatistics, University of California San Francisco

Stuart Blume, Emeritus Professor, University Of Amsterdam

Kate Broderick, Vice President, Research And Development, Inovio Pharmaceuticals

Dennis Brooks, Global Safety Physician Infection And Vaccines, Astrazeneca

Jay Butler, Deputy Director for Infectious Disease, Centers for Disease Control and Prevention

Ana Maria Carrillo, Professor, History of Public Health, Medical Faculty, National University of Mexico

Arturo Casadevall, Chairman Of Molecular Microbiology And Immunology, Johns Hopkins Bloomberg School of Public Health

Gabe Charbonneau, Vice President, United Physicians

Robert Chen, Scientific Director, Brighton Collaboration, a program of the Task Force for Global Health

Scott Cohen, Co-Founder, New Lab

Gaetano Cordone, Deputy Executive Director, Planning, Program Analysis and Evaluation, U.S Customs and Border Protection Attache American Embassy

Andrea Crisanti, Professor of Microbiology and Virology, University of Padova

Sharon Deem, Director, Saint Louis Zoo Institute for Conservation

Frank Derosa, Chief Technology Officer, Translate Bio

Cynthia Dukes, VP, Drug Development Services and Global Head of Vaccine Center of Excellence, ICON Clinical Research

Jonathan Dyer, Global Affairs Journalist, Independant

Kathryn Edwards, Professor, Scientific Director, Vanderbilt Vaccine Research Program, Vanderbilt University

Bill Farley, VP, Business Development, Sorrento Therapeutics Inc

Gian Gandhi, Chief of Markets and Supplier Financing Center, UNICEF

Vimal Gandhi, Senior Director, External Manufacturing, COVID-19 Vaccine, AstraZeneca

Dylan George, Member Of Technical Staff, IQT

Jacob Glanville, Co-Founder, President And Chief Executive Officer, Distributed Bio Llc

Elana Gordon, Reporter & Producer, The World

Gregory Gray, Professor, Duke University School of Medicine

Claudio Guarnieri, Head of Security Lab, Amnesty International

Farshad Guirakhoo, CSO, Covaxx

David Harris, Managing Director, Charles Hamilton Houston Institute for Race & Justice, Harvard Law School

Kathleen Hefferon, Instructor, Department of Microbiology, Cornell University

Syed Husain, Senior Vice President & Head of CDMO Business Unit, Emergent BioSolutions

Lisa Jarvis, Senior Editor, C&EN

Henry Ji, Chairman, President, and CEO, Sorrento Therapeutics Inc

Laura Kahn, Co-Founder, One Health Initiative

Alena Khromava, Senior Director, Head of Pharmacoepidemiology and Risk Management, Sanofi Pasteur

Lisa Kierstead, Executive Director, Lab Operations, PPD

Martina Kovac, Vice President, Global Product Development – Vaccines, PPD

Craig Laferrière, Head of Vaccine Development, Novateur Ventures Inc.

Dana Lewis, Co-Founder, CoEpi

George Lueddeke, Chair, One Health Education Task Force, One Health Commission

Louis Macareo, Executive Director, New Diseases Vaccines Lead, Merck Research Laboratories

Catherine Machalaba, Policy Advisor and Research Scientist, Ecohealth Alliance Inc.

Joan Mannick, Chief Medical Officer, ResTORbio

Francesco Marconi, Co-founder and Chief Data Officer, Applied XL

Peter Marks, Director, Center For Biologics Evaluation And Research (CBER), U.S. Food and Drug Administration

Phillip Martin, Senior Investigative Reporter, WGBH News

Melissa Marx, Assistant Professor, Global Disease Epidemiology and Control, Infectious Disease Epidemiology, Johns Hopkins Bloomberg School of Public Health

Jon Medved, Founder and Chief Executive Officer, OurCrowd

Tim Meehan, Ad hoc COVID-19 Diagnostics Scientist and Hepatitis Diagnostics Program Manager, Clinton Health Access Initiative (CHAI)

Jack Michel, President and Chairman of the Board, Larkin Community Hospital

Michael Mina, Assistant Professor, Epidemiology, Harvard T.H. Chan School of Public Health

Arun Mishra, Head, Global Nutrition Regulatory Affairs and Global Health & Wellness Regulatory Affairs, Unilever

Carol Pearson, Health Reporter, Voice of America

Peter Rabinowitz, Director, UW Center for One Health Research

Rino Rappuoli, Chief Scientist, and Head External R&D, GSK Vaccines

Rino Rappuoli | Chief Scientist, and Head External R&D | GSK Vaccines » speaking at Disease Prevention

Tim Rich, Executive Director, Innovation and Virtual Trials, PPD

Erin Riglin, VP of Platform & Data Engineering, Applied XL

Michael Riley, President, Catalent Biologics - North America

Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Vaccines & Prevention B.V.

Edward Salsberg, Lead Research Scientist, George Washington University School of Public Health and Health Services

Aaron Sato, Chief Scientific Officer, Twist Bioscience

Debra Schaumberg, Vice President, Scientific Affairs, Real-World Evidence, Evidera

Thomas Seoh, EVP and Board Member, The Kitalys Institute

Seema Shah, Associate Professor, Pediatrics, Northwestern University Medical School

Kosali Simon, Herman Wells Endowed Professor, Associate Vice Provost for Health Sciences, Indiana University

Moncef Slaoui, Chief Advisor, Operation Warp Speed

Walter Straus, Avp, Merck And Company

Cheryl Stroud, Executive Director, One Health Commission

Nasrin Sultana, COVID-19 Contact Tracing Specialist, Larkin Community Hospital

Wellington Sun, Consultant, Vaxcellerant LLC

Valentin-Veron Toma, Senior Researcher, Institute of Anthropology “Francisc I. Rainer”

Lloyd Tran, Chairman & CEO, Biomed Industries, Inc.

Neeta Verma, Director General, National Informatics Centre

Steve Waters, CEO, CONTRACE

Tal Zaks, Chief Medical Officer, Moderna Therapeutics

Tal Zaks | Chief Medical Officer | Moderna Therapeutics » speaking at Disease Prevention

REGISTER NOW